Myriad Genetics announces first quarter 2024 financial results: revenue growth exceeds expectations amid challenges
income: Revenue in the first quarter of 2024 is expected to be $202 million, an increase of 12% year-over-year, exceeding the estimate of $193.51 million. Net loss: Net loss for …